F/m Emerald Life Sciences Innovation ETF Rating $40.93 -1.10 (-2.61%) Closing price 10/13/2026 03:57 PM EasternExtended Trading$40.94 +0.00 (+0.00%) As of 10/13/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort Interest F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.76Holdings in LFSC have an aggregate rating of Moderate Buy based on 329 analyst ratings issued in the past year covering 25 companies (90.2% of the portfolio).LFSC Aggregate Price Target$40.93High Prediction$40.93Average Prediction$40.93Low Prediction$40.93Holdings in LFSC have an aggregate price target of $40.93 and a range of $40.93 to $40.93 covering 25 companies (90.2% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings7.73%CORTCorcept Therapeutics$117.80-2.8%Moderate Buy$138.17 17.3%84.0419 of 5 stars6.81%LIVNLivaNova$76.37-1.2%Moderate Buy$87.75 14.9%113.2423 of 5 stars6.18%TVTXTravere Therapeutics$51.80-0.4%Moderate Buy$69.50 34.2%123.1791 of 5 stars6.17%COGTCogent Biosciences$28.09-5.7%Moderate Buy$51.56 83.5%122.8471 of 5 starsPositive News5.34%GHGuardant Health$162.09-0.4%Moderate Buy$190.00 17.2%252.3743 of 5 starsAnalyst Forecast5.18%SYRESpyre Therapeutics$80.45-6.3%Moderate Buy$110.40 37.2%172.6012 of 5 starsAnalyst Upgrade4.63%REPLReplimune Group$12.11-7.3%Moderate Buy$12.00 -0.9%101.0958 of 5 stars4.49%BLLNBilliontoone$94.44+1.5%Moderate Buy$126.25 33.7%114.1568 of 5 stars4.10%MANEVeradermics$115.96-5.3%Moderate Buy$153.00 31.9%91.8471 of 5 stars3.61%MIRMMirum Pharmaceuticals$79.62-7.5%Moderate Buy$146.63 84.2%153.1502 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.34%CYTKCytokinetics$61.62-1.9%Moderate Buy$106.06 72.1%202.5746 of 5 starsTrending NewsAnalyst UpgradeInsider Trade3.30%TMDXTransMedics Group$79.14+1.2%Hold$115.60 46.1%124.065 of 5 starsAnalyst Forecast3.27%AXSMAxsome Therapeutics$156.32-5.8%Moderate Buy$275.74 76.4%213.148 of 5 starsAnalyst Forecast2.82%SVRASavara$4.78-1.2%Moderate Buy$10.25 114.4%82.1194 of 5 starsNews Coverage2.76%ICUIICU Medical$163.23-0.4%Moderate Buy$192.80 18.1%93.4419 of 5 starsPositive News2.63%UTHRUnited Therapeutics$543.40-1.2%Moderate Buy$639.08 17.6%143.963 of 5 starsTrending NewsAnalyst ForecastInsider Trade2.51%TWSTTwist Bioscience$151.33-0.3%Hold$143.67 -5.1%131.9877 of 5 starsAnalyst ForecastInsider Trade2.27%DNTHDianthus Therapeutics$77.58-4.9%Moderate Buy$129.83 67.4%152.4657 of 5 starsNews CoveragePositive News2.21%TRVITrevi Therapeutics$12.29-4.9%Moderate Buy$27.08 120.4%132.9191 of 5 starsNews Coverage2.19%VRDNViridian Therapeutics$18.22-0.4%Moderate Buy$38.69 112.4%132.8946 of 5 stars2.11%PVLAPalvella Therapeutics$128.51-4.4%Moderate Buy$207.43 61.4%152.2221 of 5 starsAnalyst ForecastAnalyst Revision1.84%NKTRNektar Therapeutics$37.92-4.8%Moderate Buy$130.67 244.6%162.8848 of 5 starsAnalyst Forecast1.84%CBLLCeriBell$26.14+3.5%Moderate Buy$27.00 3.3%71.739 of 5 starsNews Coverage1.53%CRVSCorvus Pharmaceuticals$9.41-6.4%Moderate Buy$33.33 254.2%82.1677 of 5 starsPositive News1.36%ATECAlphatec$10.82-3.8%Moderate Buy$17.40 60.8%153.8548 of 5 starsAnalyst Downgrade This page (NASDAQ:LFSC) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Play Kevin O'Leary Is BackingKevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...The Tomorrow Investor | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredFox News: Wall Street Can Seize Your RetirementFox News reported that under current law, legal title to most stocks and bonds sits with a central institution...Monetary Gold | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
